InvestorsHub Logo

frenchbroad

04/09/23 11:18 AM

#397319 RE: TheHound #397317

Shift change. Excellent potential and value in Brilacidin. Have a look. Tested in laboratories and hospitals and humans all around the big world. Anti-bacterial and anti-viral and anti-fungal and anti-inflammatory. And safe. More is learned every day and the value accelerates. Two Fast Track designations and one QIDP from the USA FDA. I am happy I bought an other big bag full of Ipix action below USD$.015.
https://www.google.com/search?client=firefox-b-1-d&q=google+scholar+brilacidin
https://www.google.com/search?client=firefox-b-1-d&q=clinical+trials+brilacidin#ip=1
https://www.ipharminc.com/stages-of-development